Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

cbdMD Q3 Gaap EPS $(0.15) Beats $(0.62) Estimate, Sales $5.17M Beat $4.93M Estimate

Author: Benzinga Newsdesk | August 14, 2024 04:24pm
cbdMD (AMEX:YCBD) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.62) by 75.81 percent. This is a 87.07 percent increase over losses of $(1.16) per share from the same period last year. The company reported quarterly sales of $5.17 million which beat the analyst consensus estimate of $4.93 million by 4.95 percent. This is a 15.44 percent decrease over sales of $6.12 million the same period last year.

Posted In: YCBD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist